Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027121 (
myositis
)
4,538
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The cellular isoform of the prion protein (
PrPc
) is a glycosylphosphatidylinositol-anchored glycoprotein, normally expressed in neural and non-neural tissues, including skeletal muscle. In transmissible spongiform encephalopathies, or prion diseases,
PrPc
, which is soluble in nondenaturing detergent and sensitive to proteinase K (PK)-treatment, represents the molecular substrate for the production of a detergent-insoluble and PK-resistant isoform, termed
PrP
(Sc). In human prion diseases,
PrP
(Sc) accumulation occurs only in brain tissues, with the exception of new variant Creutzfeldt-Jakob disease, where
PrP
(Sc) is also detected in lymphoid tissues. Increased amounts of prion protein expression and deposition have been described in pathological muscle fibers of two human muscle disorders, called sporadic inclusion-body
myositis
(s-IBM) and hereditary inclusion-body myopathy, but it is unknown whether accumulated prion protein reflects normal
PrPc
or
PrP
(Sc). We investigated the biochemical characteristics of prion protein in normal human muscle, s-IBM, other inflammatory myopathies and denervation atrophy. We report that 1) both the glycoform profile and size of the normal muscle
PrPc
are different from those of human brain
PrPc
; 2) in addition to s-IBM, increased
PrPc
expression is seen in polymyositis, dermatomyositis and neurogenic muscle atrophy, but
PrPc
glycoforms are unchanged; 3) only the normal
PrPc
isoform, and not
PrP
(Sc), is detected in s-IBM. The present results exclude that s-IBM is a prion disease.
...
PMID:Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy. 1130 93